Key result
In a retrospective analysis of 25 fatal cases of premortem diagnosed pulmonary thromboembolism, 76% had two or more risk factors, and survival duration was longer in patients who underwent surgery compared to those receiving thrombolysis or LMWH.
Observational (n=25)
No
In patients with fatal pulmonary thromboembolism, surgical intervention was associated with longer survival durations compared to medical therapy, highlighting the need for timely intervention in high-risk patients.
Objectives: We analyzed patients diagnosed premortem with pulmonary thromboembolism (PTE), focusing on causes of failure of therapy together with clinical characteristics. Methods: This was a retrospective study of 25 cases. We classified PTE as massive, submassive and nonmassive. Results: Of the 25 cases, 76% (19/25) had two or more risk factors for PTE. The point of origin of PE could be determined in only 44% of 25 cases. In 20 % (5/25) of cases diagnosed with PTE a maximum 3 months prior to death, the main cause of death was unknown. Of 10/20 (50%) massive and 8/20 (40%) submassive PTE cases, 5 and 3 underwent thrombolysis therapy, respectively. Both of 2/20 (10%) non-massive PTE cases underwent LMWH; in 1 of these cases, autopsy showed thrombus of a large pulmonary artery at 25 days after therapy. Submassive PTE cases were older and had a greater number of risk factors than did massive PTE cases. The point of origin of PTE was a right heart thrombus in six (24%) cases. Surgeries were performed in 3/6 (50 %) cases with right atrial thrombus. The survival duration after therapy in those who underwent surgery was longer than those who received thrombolysis and LMWH therapies. Conclusions: Physicians may provide appropriate information to patients who have certain risk factors (trauma, surgery, pregnancy, etc.) to predict acute PE at a preventable stage. If risk factors are present for a prolonged period, or if new risk factors for PTE are identified, patients should be followed up carefully because of the risk of progression of thrombosis.
No takes yet. Share an insight, caveat, or question.
Yakar et al. (2016) conducted an observational in Pulmonary thromboembolism (n=25). Thrombolysis, LMWH, or Surgery was evaluated on Causes of failure of therapy and clinical characteristics. In a retrospective analysis of 25 fatal cases of premortem diagnosed pulmonary thromboembolism, 76% had two or more risk factors, and survival duration was longer in patients who underwent surgery compared to those receiving thrombolysis or LMWH.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: